Clinical Trial Update: Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy

View source ↗

Summary

A clinical trial investigating whether microbiome analysis can predict treatment response and toxicity after concurrent chemoradiotherapy in non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Leiden University Medical Center | Conditions: Non Small Cell Lung Cancer Stage III, Immunotherapy | Status: ACTIVE_NOT_RECRUITING